These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 20234129)

  • 1. Hemochromatosis and hemojuvelin G320V homozygosity in a Hungarian woman.
    Várkonyi J; Lueff S; Szucs N; Pozsonyi Z; Tóth A; Karádi I; Pietrangelo A
    Acta Haematol; 2010; 123(3):191-3. PubMed ID: 20234129
    [No Abstract]   [Full Text] [Related]  

  • 2. Juvenile hemochromatosis due to homozygosity for the G320V mutation in the HJV gene with fatal outcome.
    Brakensiek K; Fegbeutel C; Mälzer M; Strüber M; Kreipe H; Stuhrmann M
    Clin Genet; 2009 Nov; 76(5):493-5. PubMed ID: 19796184
    [No Abstract]   [Full Text] [Related]  

  • 3. Juvenile hemochromatosis caused by a novel combination of hemojuvelin G320V/R176C mutations in a 5-year old girl.
    Aguilar-Martinez P; Lok CY; Cunat S; Cadet E; Robson K; Rochette J
    Haematologica; 2007 Mar; 92(3):421-2. PubMed ID: 17339196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic cerebellar ataxia and hereditary hemochromatosis: causal or coincidental association?
    Rutgers MP; Pielen A; Gille M
    J Neurol; 2007 Sep; 254(9):1296-7. PubMed ID: 17450315
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of new mutations of hepcidin and hemojuvelin in patients with HFE C282Y allele.
    Biasiotto G; Roetto A; Daraio F; Polotti A; Gerardi GM; Girelli D; Cremonesi L; Arosio P; Camaschella C
    Blood Cells Mol Dis; 2004; 33(3):338-43. PubMed ID: 15528154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Juvenile hemochromatosis due to G320V/Q116X compound heterozygosity of hemojuvelin in an Irish patient.
    Daraio F; Ryan E; Gleeson F; Roetto A; Crowe J; Camaschella C
    Blood Cells Mol Dis; 2005; 35(2):174-6. PubMed ID: 15967692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homozygous G320V mutation in the HJV gene causing juvenile hereditary haemochromatosis type A. A case report.
    Militaru MS; Popp RA; Trifa AP
    J Gastrointestin Liver Dis; 2010 Jun; 19(2):191-3. PubMed ID: 20593054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low clinical penetrance of homozygosity for HFE C282Y: implications for genetic testing?
    Födinger M; Sunder-Plassmann G
    Eur J Clin Invest; 2003 Sep; 33(9):737-9. PubMed ID: 12925029
    [No Abstract]   [Full Text] [Related]  

  • 9. Letter by Sullivan regarding article, "HFE C282Y homozygosity is associated with lower total and low-density lipoprotein cholesterol: the hemochromatosis and iron overload screening study".
    Sullivan JL
    Circ Cardiovasc Genet; 2009 Jun; 2(3):e1. PubMed ID: 20031587
    [No Abstract]   [Full Text] [Related]  

  • 10. What is HFE haemochromatosis?
    Marjot T; Collier J; Ryan JD
    Br J Hosp Med (Lond); 2016 Jun; 77(6):C91-5. PubMed ID: 27269766
    [No Abstract]   [Full Text] [Related]  

  • 11. HLA haplotype A*03-B*07 in hemochromatosis probands with HFE C282Y homozygosity: frequency disparity in men and women and lack of association with severity of iron overload.
    Barton JC; Wiener HW; Acton RT; Go RC
    Blood Cells Mol Dis; 2005; 34(1):38-47. PubMed ID: 15607698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High frequency of the haemochromatosis C282Y mutation in Hungary could argue against a Celtic origin of the mutation.
    Tordai A; Andrikovics H; Kalmár L; Rajczy K; Pénzes M; Sarkadi B; Klein I; Váradi A
    J Med Genet; 1998 Oct; 35(10):878-9. PubMed ID: 9783719
    [No Abstract]   [Full Text] [Related]  

  • 13. Autoimmune Conditions in 235 Hemochromatosis Probands with HFE C282Y Homozygosity and Their First-Degree Relatives.
    Barton JC; Barton JC
    J Immunol Res; 2015; 2015():453046. PubMed ID: 26504855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency and spectrum of hemochromatosis mutations in Tunisia.
    Zorai A; Harteveld CL; Rachdi R; Dellagi K; Abbes S; Delbini P; Giordano PC
    Hematol J; 2003; 4(6):433-5. PubMed ID: 14671616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural history of hemochromatosis.
    Beutler E
    Mayo Clin Proc; 2004 Mar; 79(3):305-6. PubMed ID: 15008601
    [No Abstract]   [Full Text] [Related]  

  • 16. HFE gene and hemochromatosis.
    Anderson GJ; Ramm GA; Subramaniam VN; Powell LW
    J Gastroenterol Hepatol; 2004 Jun; 19(6):712. PubMed ID: 15151632
    [No Abstract]   [Full Text] [Related]  

  • 17. Decreased cardiovascular and extrahepatic cancer-related mortality in treated patients with mild HFE hemochromatosis.
    Bardou-Jacquet E; Morcet J; Manet G; Lainé F; Perrin M; Jouanolle AM; Guyader D; Moirand R; Viel JF; Deugnier Y
    J Hepatol; 2015 Mar; 62(3):682-9. PubMed ID: 25450707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical guidelines: HFE hemochromatosis-screening, diagnosis and management.
    Barton JC; Adams PC
    Nat Rev Gastroenterol Hepatol; 2010 Sep; 7(9):482-4. PubMed ID: 20811364
    [No Abstract]   [Full Text] [Related]  

  • 19. Allele frequencies of hemojuvelin gene (HJV) I222N and G320V missense mutations in white and African American subjects from the general Alabama population.
    Barton JC; Rivers CA; Niyongere S; Bohannon SB; Acton RT
    BMC Med Genet; 2004 Dec; 5():29. PubMed ID: 15610558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in HFE, the hemochromatosis candidate gene, in patients with NIDDM.
    Dubois-Laforgue D; Caillat-Zucman S; Djilali-Saiah I; Larger E; Mercadier A; Boitard C; Bach JF; Timsit J
    Diabetes Care; 1998 Aug; 21(8):1371-2. PubMed ID: 9702455
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.